Sorafenib treatment for papillary thyroid carcinoma with diffuse lung metastases in a child with autism spectrum disorder: a case report

Abstract Background Pediatric papillary thyroid carcinoma frequently presents with lymph node involvement and distant metastases. Sorafenib, an oral multikinase inhibitor, has been used to treat radioactive iodine (RAI) therapy-refractory thyroid carcinoma in adults; however, pediatric experience is...

Description complète

Détails bibliographiques

Auteurs principaux:	Yousuke Higuchi, Takayuki Motoki, Hisashi Ishida, Kiichiro Kanamitsu, Kana Washio, Takanori Oyama, Takuo Noda, Yasuko Tsurumaru, Ayumi Okada, Hirokazu Tsukahara, Akira Shimada
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2017-11-01
Collection:	BMC Cancer
Sujets:	Sorafenib Pediatrics Papillary thyroid carcinoma Lung metastases Autism spectrum disorder
Accès en ligne:	http://link.springer.com/article/10.1186/s12885-017-3782-7
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!